TokenPost·
Corvus Pharmaceuticals' R&D Spending Rises to $17.8 Million in Q3
Expenses were $8.5 million in the year-earlier quarter, Chief Financial Officer Leiv Lea said.
More news
- CoinGapeXRP, DOGE & ADA Price Outlook: How Low Can These Altcoins Drop Next?
- TokenPostHuawei’s Horinger Capacity Is Estimated at 7.3% of xAI’s Colossus 2
- TokenPostTactfolio Announces AI Strategy Platform for Daily Stock Trading
- TokenPostSolana Foundation Validator Program Has 12-Month Term, Conflicting Exit Thresholds
- TokenPosteGain Targets 20% AI Customer ARR Growth as Sales Spending Rises
- TokenPostLumens Futures Open Interest Falls Ahead of Stellar's Bell Vote